- £3.53bn
- £5.62bn
- £418.00m
- 64
- 58
- 96
- 87
2019 March 31st | 2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 904 | 613 | 468 | 412 | 418 |
Cost of Revenue | |||||
Gross Profit | 505 | 415 | 348 | 277 | 312 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 497 | 290 | 226 | 176 | 215 |
Operating Profit | 407 | 323 | 242 | 236 | 203 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -319 | -1,116 | -1,053 | 963 | -1,034 |
Provision for Income Taxes | |||||
Net Income After Taxes | -320 | -1,114 | -1,083 | 965 | -1,039 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -291 | -1,027 | -1,031 | 963 | -1,038 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -291 | -1,027 | -1,031 | 963 | -1,038 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.3 | -1.1 | -1.11 | 1.04 | -1.12 |
Dividends per Share |